IL6 and posterior cortical atrophy: Inflammatory cytokine-resistant, IL-6-positive LNCaP cells, established after prolonged IL-6 treatment, display growth advantages in vitro and in vivo, similar to late-stage PCa cells [27], and these cells are resistant to cytokine-induced apoptosis.